Leonteq Securities AG’s Clovis Oncology, Inc. CLVS Stock Holding History

Leonteq Securities AG’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-114,500	Closed	-$136K	–	1385
2022 Q3	$136K	Buy	114,500 +6,000	+6%	+$9.35K	0.01%	596
2022 Q2	$195K	Buy	108,500 +11,000	+11%	+$16.2K	0.01%	560
2022 Q1	$197K	Buy	97,500 +66,500	+215%	+$131K	0.01%	594
2021 Q4	$84K	Hold	31,000	–	–	﹤0.01%	809
2021 Q3	$138K	Hold	31,000	–	–	0.01%	661
2021 Q2	$180K	Buy	31,000 +1,000	+3%	+$5.86K	0.01%	594
2021 Q1	$211K	Sell	30,000 -16,200	-35%	-$109K	0.01%	545
2020 Q4	$222K	Buy	+46,200	New	+$234K	0.01%	551

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Leonteq Securities AG's CLVS Position: Q4 2022 in Review

Leonteq Securities AG sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 114,500 shares — an estimated $136K sold.

Leonteq Securities AG first reported a position in CLVS in Q4 2020 and held it in 8 quarters. The position peaked at $222K in Q4 2020. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Leonteq Securities AG reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Leonteq Securities AG sold 114,500 Clovis Oncology, Inc. shares in Q4 2022, an estimated $136K.
Leonteq Securities AG first reported a position in Clovis Oncology, Inc. in Q4 2020 and held it in 8 quarters.
Leonteq Securities AG's Clovis Oncology, Inc. position peaked at $222K in Q4 2020.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Leonteq Securities AG's 13F filing for Q4 2022, filed 26 Mar 2026.